[Federal Register Volume 64, Number 225 (Tuesday, November 23, 1999)]
[Notices]
[Pages 65713-65714]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-30527]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
The 2000 FDA Science Forum--FDA and the Science of Safety: New
Perspectives
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice of meeting.
-----------------------------------------------------------------------
The Food and Drug Administration (FDA), Office of Science is
announcing the following meeting entitled ``The 2000 FDA Science
Forum--FDA and the Science of Safety: New Perspectives.'' The forum is
devoted to the presentation and sharing of data, knowledge, and ideas
among the diverse disciplines of risk management. The forum will bring
FDA scientists together with industry, academia, government agencies,
consumer groups, and the public to explore the scientific and practical
issues related to the safety evaluation and risk management of FDA-
regulated products.
Date and Time: The forum will be held on Monday, February 14, 2000,
from 8:30 a.m. to 7 p.m., and Tuesday, February 15, 2000, from 8:30
a.m. to 4:30 p.m.
Location: Washington Convention Center, rms. 29 to 32 (lower
level), and Hall C (upper level), 900 Ninth St. NW., Washington, DC
20001.
Contact: American Association of Pharmaceutical Scientists, 703-
548-3000, or Donna L. Mentch, Food and Drug Administration, Office of
Science (HF-33), 5600 Fishers Lane, Rockville, MD 20857, 301-827-3340,
e-mail: dmentch@oc.fda.gov.
Registration: Attendees may register from 7 a.m. to 5 p.m. on
February 14, 2000, and from 8 a.m. to 1 p.m. on February 15, 2000.
Fees, registration, and program information are also available at
www.aaps.org/edumeet/fdasf/index.html or from the contact persons
listed above. Attendance will be limited; therefore, interested parties
are encouraged to register early.
SUPPLEMENTARY INFORMATION: The meeting is cosponsored by FDA's Office
of Science, the American Association of Pharmaceutical Scientists,
FDA's Office of Women's Health, and FDA's Chapter of Sigma Xi the
Scientific Research Society. Speakers and panelists will address
emerging issues in the safety assessment of foods, human and animal
drugs, biologics, and medical devices. Plenary lectures and discussion
groups will provide perspectives on the following topics:
(1) Walking and Talking: The Art and Science of Risk Communication;
[[Page 65714]]
(2) Contemporary Issues in Risk Assessment;
(3) Postmarket Surveillance--Beyond Passive Surveillance;
(4) The Food Safety Initiative--The Risk Perspective;
(5) New Scientific Perspectives: Women's Health and the Science of
Gender Differences; and
(6) Risk Assessment in Action.
If you need special accommodations due to a disability, please
contact the American Association of Pharmaceutical Scientists at least
3 weeks in advance.
Dated: November 17, 1999.
William K. Hubbard,
Senior Associate Commissioner for Policy, Planning, and Legislation.
[FR Doc. 99-30527 Filed 11-22-99; 8:45 am]
BILLING CODE 4160-01-F
